Business Context and Reporting Period
This Form 8-K Current Report is filed by Mustang Bio, Inc. for the reporting period ending September 30, 2019. The company is incorporated in Delaware and its common stock trades on the NASDAQ Global Market under the symbol MBIO. The filing primarily addresses a corporate governance action regarding the company's capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a Current Report (Form 8-K) focused on a specific corporate event rather than a periodic financial statement (such as a 10-K or 10-Q) containing comprehensive financial data.
Material Changes
The material change reported is the amendment of the company's Amended and Restated Certificate of Incorporation. Specifically:
- Authorized Share Increase: The authorized number of shares of common stock (par value $0.0001) was increased from 50,000,000 to 85,000,000.
- Approval Process: The Board of Directors approved the amendment on August 16, 2019. Stockholder approval was obtained via written consent in lieu of a meeting on the same date.
- Effective Date: The amendment became effective upon filing the Certificate of Amendment with the Delaware Secretary of State on September 30, 2019.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural details of the capitalization amendment.
Investor Verification Checklist
- Verify the impact of the increased authorized share count (from 50M to 85M) on potential future dilution.
- Review the referenced Information Statement filed on September 10, 2019, for the full rationale behind the amendment.
- Confirm the current outstanding share count to understand the remaining unissued authorized shares.
- Check subsequent filings for any immediate issuance of shares from the newly authorized pool.